SCHEMBL845235

SCHEMBL845235

CCC(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)Cc3cccs3)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.50
ALDH1A1 P00352 2/20 0.50
HTT P42858 1/20 0.50
NPSR1 Q6W5P4 1/20 0.46
MAPT P10636 2/20 0.46
PABPC1 P11940 1/20 0.43
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
POLB P06746 2/20 0.41
GAA P10253 1/20 0.41
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
MEN1 O00255 1/20 0.41
ESR1 P03372 1/20 0.41
KMT2A Q03164 1/20 0.41
ESR2 Q92731 1/20 0.41
CTDSP1 Q9GZU7 1/20 0.41
APOBEC3A P31941 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13272192 1.00 MAPK1 (0.52) MAPK1L3MBTL1SMN1; SMN2ALDH1A1HTT
SCHEMBL845304 0.93 MAPK1 (0.52) MAPK1L3MBTL1SMN1; SMN2ALDH1A1HTT
SCHEMBL13272186 0.91 MAPK1 (0.51) MAPK1L3MBTL1SMN1; SMN2ALDH1A1HTT
SCHEMBL845288 0.91 MAPK1 (0.51) MAPK1L3MBTL1SMN1; SMN2ALDH1A1HTT
SCHEMBL844977 0.90 MAPK1 (0.50) MAPK1L3MBTL1SMN1; SMN2ALDH1A1HTT
SCHEMBL844967 0.90 MAPK1 (0.50) MAPK1L3MBTL1SMN1; SMN2ALDH1A1HTT
SCHEMBL845486 0.90 MAPK1 (0.50) MAPK1L3MBTL1SMN1; SMN2ALDH1A1HTT
SCHEMBL845251 0.87 PABPC1 (0.50) MAPK1ALDH1A1HTTPABPC1CYP2C9
SCHEMBL2196617 0.80 ALDH1A1 (0.54) MAPK1L3MBTL1SMN1; SMN2ALDH1A1HTT
SCHEMBL14648164 0.80 ALDH1A1 (0.54) MAPK1L3MBTL1SMN1; SMN2ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed